Showing posts with label
Cabaletta Bio
.
Show all posts
Showing posts with label
Cabaletta Bio
.
Show all posts
Friday, September 19, 2025
Cabaletta Bio $CABA might just be that "needle in the haystack" of Microcap BioTechs poised for greater things
›
Here’s a fresh, single-page style investment/business report on Cabaletta Bio (NASDAQ: CABA) that pulls in the August–September 2025 filing...
Friday, August 8, 2025
Here’s the latest on Cabaletta Bio Inc. (NASDAQ: CABA) as August 2025
›
Why CABA Could “Pop” with Catalysts This Summer 1. Clear Regulatory Path & BLA Target Cabaletta secured RMAT designation and recently a...
Friday, June 27, 2025
When the tech "hits the fan" so to speak, who might bid for Cabaletta Bio and their cutting edge technology?
›
Cabaletta Bio is a compelling acquisition target in a growing niche— cell therapy for autoimmune diseases . Its unique platform, strong e...
›
Home
View web version
